Gilead and GSK go head-to-head with similar HIV drug data

Reuters: Health News

Gilead and GSK go head-to-head with similar HIV drug data

(This story corrects story published on May 30 to show that two, not three, of the studies had enrolled previously untreated patients, in third and fourth paragraphs from the bottom.)

more info...